About
We focus on muscle diseases, including Congenital Myopathies and FSHD, aiming for personalized treatments, patient involvement, and improved quality of life through new therapies.
Research group leader
prof. dr. Nicol Voermans
Aims
We aim to translate newly identified (digital, imaging and molecular) biomarkers, novel therapies (small molecules, antisense oligonucleotides and cell therapies) and rehabilitation strategies into clinical care and to evaluate their effect on quality of life.
Research programs
Programs that are connected to this research group.